ArticleJournal of experimental & clinical cancer research : CR2019

Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.

Honghong Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.